Announced
Completed
Laureus Capital led a $26m Series B round Ethris.
Synopsis
Laureus Capital, a private equity firm, led a $26m Series B round Ethris, a biotechnology company. “Raising this Series B financing represents an important milestone for Ethris and validates the potential of our proprietary mRNA and LNP delivery platforms and the expert team we have built,” Carsten Rudolph, Ethris CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Seller Team (2)
Bidder Team (10)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite